Article Details

Pinetree Therapeutics Announces Exclusive Option and Global License Agreement ... - Stock Titan

Retrieved on: 2024-07-23 16:00:05

Tags for this article:

Click the tags to see associated articles and topics

Pinetree Therapeutics Announces Exclusive Option and Global License Agreement ... - Stock Titan. View article details on hiswai:

Excerpt

AstraZeneca secures exclusive option for Pinetree's EGFR degrader, with potential $500M+ deal value. Promising preclinical results in resistant ...

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up